Lorenzo Beltrame
Dados Biográficos
| ID | 381444 |
|---|---|
| NOME | Lorenzo Beltrame |
| PRENOMES | Lorenzo |
| SOBRENOME | Beltrame |
| ASSINATURA | BELTRAME L |
| AFILIAÇÕES | University of Trento |
| ORCID | 0000-0001-7235-8683 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 11 |
| TOTAL DE CITAÇÕES | 13 |
| TOTAL COMO AUTOR | 11 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2013 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 2 |
Validating what counts as knowledge
In this article, we introduce the notions of algorithmic gaze and nested multifocality as analytical categories for investigating the production of evidence in contemporary biosciences. Drawing on an ethnographic study of a translational medicine project involving the clinic, the wet lab, and bioinformatic work—as well as interviews with bioinformaticians and computational biologists—we show how evidence emerges through the situated negotiation o…
Dispersed HLA variability and the making of solidarity in umbilical cord blood collection in Italy
Umbilical cord blood (UCB) is a source of hematopoietic stem cells used as an alternative to bone marrow transplantation for the treatment of hematological malignancies, blood disorders, and bone marrow failure. UCB is particularly valuable for patients from ethnic minorities who are underrepresented in international bone marrow donor registries. In response, national public UCB banking systems have developed strategies to increase the number of …
Capitalization and the production of value at the nexus of academia and industry
This article analyses valuation practices, focusing on the way health data constitute different kinds of assets for different actors within an industry-academia partnership in the field of microbiome research. It examines emerging bioeconomic dynamics within data-driven computational biology, contributing to debates about the sociopolitical implications of multiple and synergic valuation practices in personalized medicine for future public health…
Values in tension. Clinical quality and civic participation in umbilical cord blood banking in Italy
In the dominant narrative of bioethics and biomedical discourse on public Umbilical Cord Blood (UCB) banking, the ethical value of donating UCB is unproblematically associated with the clinical quality of collected UCB. This article shows that this view is analytically untenable as it overlooks tensions and conflicts between the social values of donation and the clinical value of banked UCB in concrete arrangements regarding the logistics of UCB …
‘It’s a family affair’
The dominant narrative in bioethical and biomedical literature criticises private/family cord blood banking as selling a biomedical service that challenges the system of public banks that is based on voluntary donations and distributing umbilical cord blood for medical needs. While the public system is described as embedded in the social relations of reciprocity, solidarity and obligation to the collectivity, private/family banking is accused of …
Anchoring hopes in a regime of truth. The legitimizing use of cord blood-derived products in Italy
Public Umbilical Cord Blood (UCB) banking is defined by the dominant bioethics and biomedical literature as working in a regime of valuation that connects the social value of solidarity and the clinical value of collected quality UCB. Adopting the notion of registers of valuing (Heuts, F., and A. Mol. 2013. “What Is a Good Tomato? A Case of Valuing in Practice.” Valuation Studies 1 (2): 125–146), this paper challenges the aforementioned view. By …
The Italian Way to Stem Cell Research
Stem cell research regulations are highly variable across nations, notwithstanding shared and common ethical concerns. Dominant in political debates has been the so‐called embryo question. However, the permissibility of human embryonic stem cell (hESC) research varies among national regulatory frameworks. Scholars have explained differences by resorting to notions of political culture, traditions of ethical reasoning, discursive strategies and po…
The hybrid bioeconomy of umbilical cord blood banking
Umbilical cord blood (UCB) is an important source for stem cells used in clinical treatments. For this purpose, UCB has to be collected at birth and stored in biobanks. The discourse about UCB biobanking practices commonly holds that it occurs in two opposite economies, the public sector and a competing private one. They correspond with moral economies of gift-giving in a redistributive economy versus private ownership of cord blood in a market e…
Hybrid practices in cord blood banking. Rethinking the commodification of human tissues in the bioeconomy
The STS and bioethical literature on umbilical cord blood (UCB) banking nowadays discusses the field as divided into opposite institutional arrangements, public versus private banking. Public banks represent a model-sharing economy; private banks represent a market economy that capitalizes hopes and tissues, and new hybrid forms that are emerging. We challenge that this distinction is analytically valuable for understanding the various forms of m…
The Therapeutic Promise of Pluripotency and its Political use in the Italian Stem Cell Debate
Stem cell research is considered one of the most promising branches of contemporary biomedicine. The capacity to develop into almost any cell type of the mature organism—pluripotency—is associated with human embryonic stem cells (hESCs) and is regarded as having great therapeutic potential. Harvesting stem cells destroys the human embryo, however; so research on embryonic stem cells has provoked controversies. In some countries such as Italy, the…
Disputing the boundary of pluripotency. The Italian public debate on amniotic fluid-derived stem cells
Amniotic fluid-derived stem (AFS) cells were the first non-embryonic source of pluripotent stem cells discussed in Italy.AFS cells have been defined "ethical stem cells", a socio-technical label denoting an array of cellular reprogramming techniques, biological artifacts, and somatic stem cells which make it possible to obtain pluripotent stem cells while avoiding the use of human embryos.The alleged pluripotent status of these cells triggered a …
Hybrid practices in cord blood banking. Rethinking the commodification of human tissues in the bioeconomy
The STS and bioethical literature on umbilical cord blood (UCB) banking nowadays discusses the field as divided into opposite institutional arrangements, public versus private banking. Public banks represent a model-sharing economy; private banks represent a market economy that capitalizes hopes and tissues, and new hybrid forms that are emerging. We challenge that this distinction is analytically valuable for understanding the various forms of m…
Values in tension. Clinical quality and civic participation in umbilical cord blood banking in Italy
In the dominant narrative of bioethics and biomedical discourse on public Umbilical Cord Blood (UCB) banking, the ethical value of donating UCB is unproblematically associated with the clinical quality of collected UCB. This article shows that this view is analytically untenable as it overlooks tensions and conflicts between the social values of donation and the clinical value of banked UCB in concrete arrangements regarding the logistics of UCB …
The Therapeutic Promise of Pluripotency and its Political use in the Italian Stem Cell Debate
Stem cell research is considered one of the most promising branches of contemporary biomedicine. The capacity to develop into almost any cell type of the mature organism—pluripotency—is associated with human embryonic stem cells (hESCs) and is regarded as having great therapeutic potential. Harvesting stem cells destroys the human embryo, however; so research on embryonic stem cells has provoked controversies. In some countries such as Italy, the…
Disputing the boundary of pluripotency. The Italian public debate on amniotic fluid-derived stem cells
Amniotic fluid-derived stem (AFS) cells were the first non-embryonic source of pluripotent stem cells discussed in Italy.AFS cells have been defined "ethical stem cells", a socio-technical label denoting an array of cellular reprogramming techniques, biological artifacts, and somatic stem cells which make it possible to obtain pluripotent stem cells while avoiding the use of human embryos.The alleged pluripotent status of these cells triggered a …
The Therapeutic Promise of Pluripotency and its Political use in the Italian Stem Cell Debate
Stem cell research is considered one of the most promising branches of contemporary biomedicine. The capacity to develop into almost any cell type of the mature organism—pluripotency—is associated with human embryonic stem cells (hESCs) and is regarded as having great therapeutic potential. Harvesting stem cells destroys the human embryo, however; so research on embryonic stem cells has provoked controversies. In some countries such as Italy, the…
The hybrid bioeconomy of umbilical cord blood banking
Umbilical cord blood (UCB) is an important source for stem cells used in clinical treatments. For this purpose, UCB has to be collected at birth and stored in biobanks. The discourse about UCB biobanking practices commonly holds that it occurs in two opposite economies, the public sector and a competing private one. They correspond with moral economies of gift-giving in a redistributive economy versus private ownership of cord blood in a market e…
Hybrid practices in cord blood banking. Rethinking the commodification of human tissues in the bioeconomy
The STS and bioethical literature on umbilical cord blood (UCB) banking nowadays discusses the field as divided into opposite institutional arrangements, public versus private banking. Public banks represent a model-sharing economy; private banks represent a market economy that capitalizes hopes and tissues, and new hybrid forms that are emerging. We challenge that this distinction is analytically valuable for understanding the various forms of m…
The Italian Way to Stem Cell Research
Stem cell research regulations are highly variable across nations, notwithstanding shared and common ethical concerns. Dominant in political debates has been the so‐called embryo question. However, the permissibility of human embryonic stem cell (hESC) research varies among national regulatory frameworks. Scholars have explained differences by resorting to notions of political culture, traditions of ethical reasoning, discursive strategies and po…
‘It’s a family affair’
The dominant narrative in bioethical and biomedical literature criticises private/family cord blood banking as selling a biomedical service that challenges the system of public banks that is based on voluntary donations and distributing umbilical cord blood for medical needs. While the public system is described as embedded in the social relations of reciprocity, solidarity and obligation to the collectivity, private/family banking is accused of …
Anchoring hopes in a regime of truth. The legitimizing use of cord blood-derived products in Italy
Public Umbilical Cord Blood (UCB) banking is defined by the dominant bioethics and biomedical literature as working in a regime of valuation that connects the social value of solidarity and the clinical value of collected quality UCB. Adopting the notion of registers of valuing (Heuts, F., and A. Mol. 2013. “What Is a Good Tomato? A Case of Valuing in Practice.” Valuation Studies 1 (2): 125–146), this paper challenges the aforementioned view. By …
Values in tension. Clinical quality and civic participation in umbilical cord blood banking in Italy
In the dominant narrative of bioethics and biomedical discourse on public Umbilical Cord Blood (UCB) banking, the ethical value of donating UCB is unproblematically associated with the clinical quality of collected UCB. This article shows that this view is analytically untenable as it overlooks tensions and conflicts between the social values of donation and the clinical value of banked UCB in concrete arrangements regarding the logistics of UCB …
Capitalization and the production of value at the nexus of academia and industry
This article analyses valuation practices, focusing on the way health data constitute different kinds of assets for different actors within an industry-academia partnership in the field of microbiome research. It examines emerging bioeconomic dynamics within data-driven computational biology, contributing to debates about the sociopolitical implications of multiple and synergic valuation practices in personalized medicine for future public health…
Validating what counts as knowledge
In this article, we introduce the notions of algorithmic gaze and nested multifocality as analytical categories for investigating the production of evidence in contemporary biosciences. Drawing on an ethnographic study of a translational medicine project involving the clinic, the wet lab, and bioinformatic work—as well as interviews with bioinformaticians and computational biologists—we show how evidence emerges through the situated negotiation o…
Dispersed HLA variability and the making of solidarity in umbilical cord blood collection in Italy
Umbilical cord blood (UCB) is a source of hematopoietic stem cells used as an alternative to bone marrow transplantation for the treatment of hematological malignancies, blood disorders, and bone marrow failure. UCB is particularly valuable for patients from ethnic minorities who are underrepresented in international bone marrow donor registries. In response, national public UCB banking systems have developed strategies to increase the number of …
Biomedical Ethics and Regulation (7 obras) · Law (6 obras) · Political science (6 obras) · Sociology (6 obras) · Business (5 obras) · Pluripotent Stem Cells Research (5 obras) · Bioethics (4 obras) · Biology (4 obras) · Economics (4 obras) · Organ Donation and Transplantation (4 obras)